What the annual reporting season reveals about the real China in 2026
By Dawei Weng The latest annual reporting season in China has laid bare a corporate landscape…
Moonshot AI reaches $20 billion valuation as race for dominance in China heats up
By Da Cheung Beijing-based artificial intelligence startup Moonshot AI — known for its popular chatbot Kimi — is…
ByteDance’s bold bet: can its Doubao AI champion make subscriptions work in China
By Lian Ran ByteDance’s AI assistant Doubao is preparing to charge users — a move that…
China’s robotaxi rollout delayed as safety concerns force reset
By Hu Minghe China appears to have hit the pause button on its push to roll…
State-backed CICT Mobile to raise 7 billion yuan to fund satellite and 6G projects
CICT Mobile (688387.SH), the state-backed Chinese mobile communications group, has announced plans to invest 9.5 billion…
DeepSeek staff retention defies exodus fears as founder turns to funding to lock in loyalty
By Feng Yuchen Chinese AI startup DeepSeek has retained 97% of its core research and engineering…
China’s AI drug-discovery champion sees survival as the biggest challenge
By Chen Guangjing Do China’s AI drug discovery champions need to worry about survival? For Wen…
Can China’s Lightelligence become the Nvidia of the photonic age?
By Da Cheung Shares in photonics chipmaker Shanghai Xizhi Technology Co. Ltd. (01879.HK) — also known…
Alibaba’s HappyHorse bets on native audio-visual AI to redefine video generation
By Zhi Han Alibaba has officially launched the beta testing phase of its proprietary video-generation model HappyHorse 1.0,…
Xiaomi’s high-stakes gamble on custom smartphone chips
By Brent Li Chinese tech giant Xiaomi (1810.HK) recently hit a milestone in its ambitious pivot toward hardware…
Latest
- Han’s CNC rides AI infrastructure boom, but expansion brings new risks
- China demonstrates novel net-catch rocket recovery system as it races to close the gap with SpaceX
- China turns to molten salt to tackle renewable energy storage bottlenecks in the national grid
- Dramatic slowdown in China’s range-extended electric vehicle market raises concerns over Xiaomi’s strategy
- Biokin’s new cancer drug secures historic approval in China, but Western regulatory hurdles loom
